Diagnosis and Management of Alcoholic Liver Disease

被引:56
作者
Dugum, Mohannad [1 ]
McCullough, Arthur [2 ]
机构
[1] Cleveland Clin, Med Inst, Dept Internal Med, Cleveland, OH 44106 USA
[2] Cleveland Clin, Digest Dis Inst, Dept Gastroenterol & Hepatol, 9500 Euclid Ave,A30, Cleveland, OH 44195 USA
关键词
Alcoholism; Alcoholic cirrhosis; Alcoholic hepatitis; Liver transplantation;
D O I
10.14218/JCTH.2015.00008
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Alcohol is a leading cause of liver disease and is associated with significant morbidity and mortality. Several factors, including the amount and duration of alcohol consumption, affect the development and progression of alcoholic liver disease (ALD). ALD represents a spectrum of liver pathology ranging from fatty change to fibrosis to cirrhosis. Early diagnosis of ALD is important to encourage alcohol abstinence, minimize the progression of liver fibrosis, and manage cirrhosis-related complications including hepatocellular carcinoma. A number of questionnaires and laboratory tests are available to screen for alcohol intake. Liver biopsy remains the gold-standard diagnostic tool for ALD, but noninvasive accurate alternatives, including a number of biochemical tests as well as liver stiffness measurement, are increasingly being utilized in the evaluation of patients with suspected ALD. The management of ALD depends largely on complete abstinence from alcohol. Supportive care should focus on treating alcohol withdrawal and providing enteral nutrition while managing the complications of liver failure. Alcoholic hepatitis (AH) is a devastating acute form of ALD that requires early recognition and specialized tertiary medical care. Assessment of AH severity using defined scoring systems is important to allocate resources and initiate appropriate therapy. Corticosteroids or pentoxifylline are commonly used in treating AH but provide a limited survival benefit. Liver transplantation represents the ultimate therapy for patients with alcoholic cirrhosis, with most transplant centers mandating a 6 month period of abstinence from alcohol before listing. Early liver transplantation is also emerging as a therapeutic measure in specifically selected patients with severe AH. A number of novel targeted therapies for ALD are currently being evaluated in clinical trials. (C) 2015 The Second Affiliated Hospital of Chongqing Medical University. Published by XIA & HE Publishing Ltd. All rights reserved.
引用
收藏
页码:109 / 116
页数:8
相关论文
共 50 条
  • [1] The value of the CAGE in screening for alcohol abuse and alcohol dependence in general clinical populations: a diagnostic meta-analysis
    Aertgeerts, B
    Buntinx, F
    Kester, A
    [J]. JOURNAL OF CLINICAL EPIDEMIOLOGY, 2004, 57 (01) : 30 - 39
  • [2] Pentoxifylline improves short-term survival in severe acute alcoholic hepatitis: A double-blind, placebo-controlled trial
    Akriviadis, E
    Botla, R
    Briggs, W
    Han, S
    Reynolds, T
    Shakil, O
    [J]. GASTROENTEROLOGY, 2000, 119 (06) : 1637 - 1648
  • [3] Allen JP, 1997, J STUD ALCOHOL, V58, P7
  • [4] CARBOHYDRATE-DEFICIENT TRANSFERRIN AND OTHER MARKERS OF HIGH ALCOHOL-CONSUMPTION - A STUDY OF 502 PATIENTS ADMITTED CONSECUTIVELY TO A MEDICAL DEPARTMENT
    BELL, H
    TALLAKSEN, CME
    TRY, K
    HAUG, E
    [J]. ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH, 1994, 18 (05) : 1103 - 1108
  • [5] Current concepts: Liver biopsy.
    Bravo, AA
    Sheth, SG
    Chopra, S
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (07) : 495 - 500
  • [6] Hepatocellular carcinoma: clinical frontiers and perspectives
    Bruix, Jordi
    Gores, Gregory J.
    Mazzaferro, Vincenzo
    [J]. GUT, 2014, 63 (05) : 844 - 855
  • [7] Liver Transplantation for Alcoholic Liver Disease in Europe: A Study from the ELTR (European Liver Transplant Registry)
    Burra, P.
    Senzolo, M.
    Adam, R.
    Delvart, V.
    Karam, V.
    Germani, G.
    Neuberger, J.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2010, 10 (01) : 138 - 148
  • [8] A novel panel of blood markers to assess the degree of liver fibrosis
    Calès, P
    Oberti, F
    Michalak, S
    Hubert-Fouchard, I
    Rousselet, MC
    Konat, A
    Gallois, Y
    Ternisien, C
    Chevailler, A
    Lunel, F
    [J]. HEPATOLOGY, 2005, 42 (06) : 1373 - 1381
  • [9] Frequency and Outcomes of Liver Transplantation for Nonalcoholic Steatohepatitis in the United States
    Charlton, Michael R.
    Burns, Justin M.
    Pedersen, Rachel A.
    Watt, Kymberly D.
    Heimbach, Julie K.
    Dierkhising, Ross A.
    [J]. GASTROENTEROLOGY, 2011, 141 (04) : 1249 - 1253
  • [10] The Impact of Obesity and Metabolic Syndrome on Alcoholic Liver Disease
    Chiang, Dian J.
    McCullough, Arthur J.
    [J]. CLINICS IN LIVER DISEASE, 2014, 18 (01) : 157 - +